Adhera Therapeutics, Inc. Retained Earnings
Adhera Therapeutics, Inc. had Retained Earnings of -$59.98 million as of 2023-09-30, per its 10-Q filed 2023-11-20.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2023-11-20
- 2023-09-30: Retained Earnings (Accumulated Deficit) -$59.98M.
- 2023-06-30: Retained Earnings (Accumulated Deficit) -$56.42M.
- 2023-03-31: Retained Earnings (Accumulated Deficit) -$56.66M.
- 2022-12-31: Retained Earnings (Accumulated Deficit) -$55.75M; Retained Earnings (Accumulated Deficit) as first filed -$55.75M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2023-09-30 | -$59.98M 10-Q · filed 2023-11-20 | |
| 2023-06-30 | -$56.42M 10-Q · filed 2023-08-21 | |
| 2023-03-31 | -$56.66M 10-Q · filed 2023-05-22 | |
| 2022-12-31 | -$55.75M 10-Q · filed 2023-11-20 | -$55.75M 10-K · filed 2023-03-31 |
| 2022-09-30 | -$55.37M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$53.56M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | -$53.45M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | -$53.02M 10-K · filed 2023-03-31 | |
| 2021-09-30 | -$50.97M 10-Q · filed 2021-11-22 | |
| 2021-06-30 | -$46.83M 10-Q · filed 2021-08-23 | |
| 2021-03-31 | -$45.92M 10-Q · filed 2021-05-24 | |
| 2020-12-31 | -$44.61M 10-K · filed 2022-04-15 | |
| 2020-09-30 | -$43.76M 10-Q · filed 2020-11-18 | |
| 2020-06-30 | -$42.84M 10-Q · filed 2020-08-19 | |
| 2020-03-31 | -$41.55M 10-Q · filed 2020-07-06 | |
| 2019-12-31 | -$39.33M 10-K · filed 2021-04-07 | |
| 2019-09-30 | -$34.87M 10-Q · filed 2019-11-19 | |
| 2019-06-30 | -$31.92M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | -$28.79M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | -$25.85M 10-K · filed 2020-04-14 | -$25.85M 10-K · filed 2019-04-16 |
| 2018-09-30 | -$22.47M 10-Q · filed 2018-11-19 | |
| 2018-06-30 | -$14.31M 10-Q · filed 2018-08-10 | |
| 2018-03-31 | -$9.39M 10-Q · filed 2018-05-18 | |
| 2017-12-31 | -$8.03M 10-K · filed 2019-04-16 | |
| 2017-09-30 | -$5.18M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | -$4.21M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | -$3.03M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | -$1.95M 10-K · filed 2018-04-17 | |
| 2016-09-30 | -$334.06M 10-Q · filed 2016-11-21 | |
| 2016-06-30 | -$334.03M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | -$333.38M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | -$1.11M 10-K · filed 2017-03-31 | -$334.45M 10-K · filed 2016-03-30 |
| 2015-09-30 | -$335.01M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | -$336.47M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | -$337.37M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | -$337.79M 10-K · filed 2016-03-30 | |
| 2014-09-30 | -$343.59M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | -$336.47M 10-Q · filed 2014-08-19 | |
| 2014-03-31 | -$340.39M 10-Q · filed 2014-08-19 | |
| 2013-12-31 | -$331.31M 10-K · filed 2015-02-18 | |
| 2013-09-30 | -$329.35M 10-Q · filed 2014-08-07 | |
| 2013-06-30 | -$328.37M 10-Q · filed 2014-08-07 | |
| 2013-03-31 | -$328.36M 10-Q · filed 2014-08-07 | |
| 2012-12-31 | -$329.74M 10-Q · filed 2014-08-07 | |
| 2012-09-30 | -$325.69M 10-Q · filed 2012-12-05 | |
| 2012-06-30 | -$323.94M 10-Q · filed 2012-12-05 | |
| 2012-03-31 | -$325.02M 10-Q · filed 2012-12-05 | |
| 2011-12-31 | -$320.19M 10-K · filed 2014-07-22 | |
| 2011-09-30 | -$302.41M 10-Q · filed 2011-11-10 | |
| 2011-06-30 | -$298.02M 10-Q · filed 2011-08-11 | |
| 2010-12-31 | -$290.77M 10-K · filed 2012-10-10 | |
| 2008-06-30 | $108.30M 10-Q · filed 2016-08-15 | -$112.10M 10-K · filed 2015-02-18 |